Document Detail


Cardiogenic shock: therapy and prevention.
MedLine Citation:
PMID:  9491944     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiogenic shock is defined as profound circulatory failure resulting in insufficient tissue perfusion to meet resting metabolic demands. It occurs in approximately 7.5% of patients with acute myocardial infarction. Treatment strategies include inotropic agents, use of intra-aortic balloon counterpulsation, and revascularization. Current evidence supports the use of primary angioplasty. Surgery should be considered in patients with triple-vessel disease. If early catheterization is not available, thrombolytic therapy should be given to eligible patients and transfer to an interventional facility should be considered. Effective therapy for shock must also include a prevention strategy. This requires identification of patients at high risk for shock development and selection of patients who are candidates for aggressive intervention.
Authors:
W L Barry; I J Sarembock
Related Documents :
8574054 - Percutaneous left ventricular assist system using a modification of the dennis method: ...
17162524 - Intrauterine myocardial infarction: unsuspected diagnosis in the delivery room.
6898604 - Bretylium tosylate in the management of recurrent ventricular fibrillation complicating...
8606274 - Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infa...
14579094 - Assessment of left ventricular diastolic function by gated single-photon emission tomog...
22997964 - Analytical performances of the newly developed, fully automated kryptor copeptin assay:...
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Clinical cardiology     Volume:  21     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  1998 Feb 
Date Detail:
Created Date:  1998-04-21     Completed Date:  1998-04-21     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  72-80     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiotonic Agents / therapeutic use
Female
Fibrinolytic Agents / therapeutic use
Humans
Intra-Aortic Balloon Pumping / methods
Middle Aged
Myocardial Contraction
Myocardial Revascularization / methods
Shock, Cardiogenic / physiopathology,  prevention & control,  therapy*
Thrombolytic Therapy / methods
Treatment Outcome
Ventricular Dysfunction, Left / physiopathology,  therapy
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Present imperfect: a critical review of animal models of the mnemonic impairments in Alzheimer's dis...
Next Document:  The importance of lowering cholesterol in patients with coronary heart disease.